Enca is an experienced life science, pharma and biotechnology professional, with over 20 years of experience and a proven track record of achievement leading and managing preclinical and translational research activities and funding streams.
Prior to joining our team, she was part of NHS Blood and Transplant where she lead a research group within Stem Cells and Immunotherapies (SCI) at the John Radcliffe Hospital, Oxford. Prior to this, she was a Senior Scientist at Oxford BioMedica Ltd. At Baehl Innovation, Enca lends her expertise to multiple sectors in biotech, biotherapies, biologics and regenerative medicine, where she articulates complex information to stakeholders at all levels of seniority. She designs and sets up new strategic plans and roadmaps for life science projects, qualifies new market opportunities and participates in the establishment of collaborations and strategic alliances between academic laboratories, clinicians and our industrial clients.
Enca received her undergraduate degree, MSc and PhD in Genetics from the University of Seville, Spain and she worked as a post-doctoral fellow in the Biochemistry Department at the University of Oxford. Enca is an editor of the Cochrane Heart Review Group. She speaks fluent Spanish and English, and has basic knowledge of French.